These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18050121)

  • 1. The effect of complement factor H Y402H polymorphism on the outcome of photodynamic therapy in age-related macular degeneration.
    Seitsonen SP; Jarvela IE; Meri S; Tommila PV; Ranta PH; Immonen IJ
    Eur J Ophthalmol; 2007; 17(6):943-9. PubMed ID: 18050121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.
    Feng X; Xiao J; Longville B; Tan AX; Wu XN; Cooper MN; McAllister IL; Isaacs T; Palmer LJ; Constable IJ
    Ophthalmology; 2009 Oct; 116(10):1908-12.e1. PubMed ID: 19692124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.
    Goverdhan SV; Hannan S; Newsom RB; Luff AJ; Griffiths H; Lotery AJ
    Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy.
    Brantley MA; Edelstein SL; King JM; Plotzke MR; Apte RS; Kymes SM; Shiels A
    Eye (Lond); 2009 Mar; 23(3):626-31. PubMed ID: 18292785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacogenomics of CFH Y402H and wet age-related macular degeneration].
    Chen LL; Chen YY
    Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):144-147. PubMed ID: 28260367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation.
    Khandhadia S; Hakobyan S; Heng LZ; Gibson J; Adams DH; Alexander GJ; Gibson JM; Martin KR; Menon G; Nash K; Sivaprasad S; Ennis S; Cree AJ; Morgan BP; Lotery AJ
    Ophthalmology; 2013 Aug; 120(8):1612-8. PubMed ID: 23562165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration].
    Kubicka-Trząska A; Karska-Basta I; Kobylarz J; Dziedzina S; Sanak M; Romanowska-Dixon B
    Klin Oczna; 2016; 118(2):114-21. PubMed ID: 29912491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration.
    Wegscheider BJ; Weger M; Renner W; Steinbrugger I; März W; Mossböck G; Temmel W; El-Shabrawi Y; Schmut O; Jahrbacher R; Haas A
    Ophthalmology; 2007 Apr; 114(4):738-42. PubMed ID: 17398321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degeneration.
    Tsuchihashi T; Mori K; Horie-Inoue K; Gehlbach PL; Kabasawa S; Takita H; Ueyama K; Okazaki Y; Inoue S; Awata T; Katayama S; Yoneya S
    Ophthalmology; 2011 Jan; 118(1):93-100. PubMed ID: 20678803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
    Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M
    Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
    Brantley MA; Fang AM; King JM; Tewari A; Kymes SM; Shiels A
    Ophthalmology; 2007 Dec; 114(12):2168-73. PubMed ID: 18054635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement factor H variant Y402H and basal laminar deposits in exudative age-related macular degeneration.
    Lommatzsch A; Hermans P; Weber B; Pauleikhoff D
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1713-6. PubMed ID: 17704937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration.
    Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M
    Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement factor H Y402H polymorphism and characteristics of exudative age-related macular degeneration lesions.
    Seitsonen S; Järvelä I; Meri S; Tommila P; Ranta P; Immonen I
    Acta Ophthalmol; 2008 Jun; 86(4):390-4. PubMed ID: 17995985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population.
    Habibi I; Sfar I; Kort F; Aounallah-Skhiri H; Chebil A; Chouchene I; Bouraoui R; Limaiem R; Largheche L; Jendoubi-Ayed S; Makhlouf M; Ben Abdallah T; Ayed K; El Matri L; Gorgi Y
    Ophthalmic Res; 2013; 49(4):177-84. PubMed ID: 23306536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population.
    Soysal Y; Inan UÜ; Küsbeci T; Imirzalioğlu N
    DNA Cell Biol; 2012 Mar; 31(3):323-30. PubMed ID: 21790300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of complement factor B rs4151667 (L9H) polymorphisms and its interactional role with CFH Y402H and C3 rs2230199 (R102G) risk variants in age-related macular degeneration: a case control study.
    Roshanipour N; Laleh MG; Bonyadi M; Bonyadi MHJ; Soheilian M; Javadzadeh A; Yaseri M
    BMC Ophthalmol; 2020 Aug; 20(1):323. PubMed ID: 32762675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography.
    Teper SJ; Nowinska A; Pilat J; Wylegala E
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():108-113. PubMed ID: 26780119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice.
    Landowski M; Kelly U; Klingeborn M; Groelle M; Ding JD; Grigsby D; Bowes Rickman C
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3703-3711. PubMed ID: 30808757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
    Chowers I; Cohen Y; Goldenberg-Cohen N; Vicuna-Kojchen J; Lichtinger A; Weinstein O; Pollack A; Axer-Siegel R; Hemo I; Averbukh E; Banin E; Meir T; Lederman M
    Mol Vis; 2008; 14():1829-34. PubMed ID: 18852870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.